Abstract
The question of why man develops motion sickness may be approached from several points of view. The human species is not alone in being susceptible to motion sickness: an equivalent pattern of symptoms can be induced by appropriate types of motion in a wide range of mammals (e.g. monkeys, horses, dogs, cats, seals) in birds, and even in fish. To the evolutionist, the problem is to understand what the survival value is of a pattern of symptoms evoked by certain types of motion stimulus that culminates in vomiting. From the practical point of view, it is necessary to know what the characteristics of those forms of motion are which lead to motion sickness as compared with those that do not. Such information also gives some indication of the likely neurophysiological mechanisms involved in motion sickness. From the point of view of the physiologist, interest is focussed on the mechanisms by which orientation and motion are sensed and on the sequence of events both within the central nervous system (CNS) and in other body systems that constitute the syndrome of motion sickness. Individual susceptibility in man varies widely and attempts have been made to find psychological and physiological measures that correlate with susceptibility. A further insight into the causal mechanisms of motion sickness comes from observation of the drugs which offer some protection. Such prophylactic drugs are drawn from several pharmacological groups, an indication that several neurotransmitters may be involved in the sequence of events leading to motion sickness.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bard P, Woolsey CW, Snider RS, Mountcastle VB, Bromley RB (1947) Delimination of central nervous mechanisms involved in motion sickness. Fed Proc 6: 72
Benson AJ (1973) Use of nystagmography in the study of aircrew with spatial disorientation. In: The use of nystagmography in aviation medicine. AGARD-CP-123: A4 1–13 AGARD/ NATO, Neuilly-sur-Seine
Brand JJ (1969) The time course of action of 1-hyoscine after intramuscular injection. Br J Pharmacol 35: 202–208
Brand JJ, Perry WLM (1966) Drugs used in motion sickness. Pharmacol Rev 18: 895–924
Brooks M (1939) The etiology of seasickness. Med Rec NY 150: 23–26
Chinn NI, Plotnikoff BP (1963) Evaluation of various techniques for screening anti-motion sickness drugs. J Appl Physiol 5: 392–394
Claremont CA (1931) The psychology of seasickness. Psyche (Stuttg) 11: 86–90
Cowings P, Toscano WB (1982) The relationship of motion sickness susceptibility to learned autonomic control for symptom suppression. Aviat Space Environ Med 53: 570–575
Crow TJ (1979) Action of hyoscine on verbal learning in man. Evidence for a cholinergic link in the transition from primary to secondary memory. In: Brazier MAB (ed) Brain mechanisms in memory and learning: from the single neuron to man. Raven, New York
Davis BM, Davis KL (1980) Cholinergic mechanisms and anterior pituitary hormone secretion. Biol Psychiatry 15: 303–310
Dobie TG (1974) Airsickness in aircrew. AGARDograph AG-177, AGARD/NATO, Neuilly-sur-Seine
Doig RK, Wolf S, Wolff MS (1953) Study of gastric function in a ‘decorticate’ man with a gastric fistula. Gastroenterology 23: 40–14
Dufosse M, Ito M, Miyashita Y (1977) Functional localisation in the rabbit’s cerebellar flocculus determined in relationship with eye movements. Neurosci Lett 5: 273–277
Eversmann T, Gottsmann M, Uhlich E, Ulbrecht G, von Werder K, Scriba PC (1977) Increased secretion of growth hormone, prolactin, antidiuretic hormone and cortisol induced by the stress of motion sickness. Aviat Space Environ Med 49: 53–57
Fernandez C, Goldberg JM (1971) Physiology of peripheral neurons innervating semicircular canals of the squirrel monkey. II Response to sinusoidal stimulation and dynamics of peripheral vestibular system. J Neurophysiol 34: 661–675
Goldberg JM, Fernandez C (1980) Efferent vestibular system in the squirrel monkey. Anatomical location and influence on efferent activity. J Neurophysiol 43: 986–1025
Graybiel A (1970) Susceptibility to acute motion sickness in blind persons. Aerospace Med 44: 593–608
Graybiel A, Wood CD, Miller EF, Cramer DB (1968) Diagnostic criteria for grading the severity of acute motion sickness. Aerospace Med 39: 453–455
Graybiel A, Miller EF, Homick JL (1974) Experiment no 131. Human vestibular function. In: Proceedings of the skylab life sciences symposium. JSC-09275 NASA TM X - 58154. NASA, Lyndon B Johnson Space Centre, Houston
Graybiel A, Wood CD, Knepton J, Hoche JP, Perkins GF (1975) Human assay of anti-motion sickness drugs. Aviat Space Environ Med 46: 1107–1118
Guedry FE (1970) Conflicting sensory cues as a factor in motion sickness. In: 4th Symposium on the role of the vestibular organs in space exploration. NASA SP-187: 45–52. Office of Technology Utilisation, NASA, Washington, DC
Hargreaves J (1982) The prophylaxis of seasickness, a comparison of cinnarizine with hyoscine. Practitioner 226: 160
Hill H (1937) Benzedrine in seasickness. Br Med J 2: 1109–1112
Hill T (1984) The relationship between motion sickness susceptibility and the adaptation to post-rotary stimulation. Thesis, Coventry Polytechnic, UK
Homick JL (1979) Space motion sickness. Acta Astronautica 6: 1259–1272
Homick JL, Kohl RL, Reschke MF, Degioanni J, Cintron-Trevino NM (1983) Transdermal scopolamine in the prevention of motion sickness: Evaluation of the time course of efficacy. Aviat Space Environ Med 54: 994–1000
Irwin JA (1881) The pathology of seasickness. Lancet 2: 907–909
Ito M, Miyashita Y (1975) The effects of chronic destruction of the inferior olive upon visual modification of the horizontal vestibulo-ocular reflex of rabbits. Proc Jpn Acad 51: 716–720
James W (1882) The sense of dizziness in deaf-mutes. Am J Otol 4: 239–254
Janowski DS, Risch SC, Ziegler M, Kennedy B, Huey L (1984) A cholinomimetic model of mo- tion sickness and space adaptation syndrome. Aviat Space Environ Med 50: 1046–1051
Johnson WH, Mayne JW (1953) Stimulus required to produce motion sickness. Restriction of head movement as a preventive of airsickness - field studies on airborne troops. J Aviat Med 24: 400–411
Keist BF, Shelley WT, Byers JM, Chinn HI (1956) Effect of head immobilisation on incidence of airsickness. J Appl Physiol 8: 369–370
Kirsten EB, Sharma JN (1976) Characteristics and response differences to iontophoretically applied norepinephrine, d-amphetamine and acetylcholine on neurons in the medial and lateral vestibular nuclei of the cat. Brain Res 112: 77–90
Kottenhoff H, Lindahl LE (1960) Laboratory studies on the psychology of motion sickness. Acta Psychol 17: 89–112
Lawther A, Griffin MJ (1981) Motion sickness in sea-going passenger vessels: an interim report. Human Factors Research Unit, ISVR Southampton
Lisberger SG, Fuchs AF (1978) role of primate flocculus during rapid behavioural modification of vestibule-ocular reflex. I. Purkinje cell activity during visually guided horizontal smooth pursuit eye movements and passive head rotation. J Neurophysiol 41: 733–763
McCauley ME, Jackson WR, Wylie CD, O’Hanlon JF, Mackie RR (1976) Motion sickness incidence: exploratory studies of habituation, pitch and roll, and the refinement of a mathematical model. Technical Report 1733–2, Human Factors Research Inc, Santa Barbara Research Park, Goleta
McClure JA, Fregley AR, Molina E, Graybiel A (1972) Response from arousal and thermal sweat areas during motion sickness. Aerospace Med 43: 176–179
Minor JL (1896) Seasickness: its cause and relief. NY Med J 64: 522–523
Money KE, Cheung BS (1983) Another function of the inner ear: facilitation of the emetic response to poisons. Aviat Space Environ Med 54: 208–211
Money KE, Wood JD (1970) Neural mechanisms underlying the symptomatology of motion sickness. In: 4th Symposium on the role of the vestibular organs in space exploration. NASA SP-187: 35–44. Office of Technology Utilisation, NASA, Washington, DC
Moore HJ, Lentz JM, Geudry FE (1977) Nauseogenic visual-vestibular interation in a visual search task. Report NAMRL-1234. Naval Aerospace Medical Research Lab, Pensacola
Nowak JZ, Pilc A, Lebrecht U, Maslinski C (1977) Does histamine interact with cholinergic neurons in its cataleptogenic action in the rat? Neuropharmacology 16: 841–847
O’Hanlon JF, McCauley ME (1974) Motion sickness incidence as a function of the frequency of vertical sinusoidal motion. Aerospace Med 45: 366–369
Oman CM (1982) Space motion sickness and vestibular experiments in spacelab. Paper No 820–833, Soc Automotive Eng, 12th Intersoc conference on environmental systems
Oman CM, Lichtenberg BK, Money KE (1984) Space motion sickness monitoring experiment: Spacelab 1. In: Motion sickness: mechanisms, prediction, prevention and treatment. AGARD-CP-372: 35, 1–21. AGARD/NATO, Neuilly-sur-Seine
Precht W (1974) Physiological aspects of the efferent vestibular system. In: Kornhuber HH (ed) Vestibular system, part 2. Psychophysics, applied aspects and general interpretation. Springer, Berlin Heidelberg New York, pp 221–236 (Handbook of sensory physiology, vol 4 )
Reason JT (1968) Relation between motion sickness susceptibility, the spiral after-effect and loudness estimation. Br J Psychol 59: 385–393
Reason JT (1970) Motion sickness: a special case of sensory re-arrangement. Adv Sci 26: 386–393
Reason JT (1978) Motion sickness adaptation: a neural mismatch model. J R Soc Med 71: 819–829
Reason JT, Brand JJ (1975) Motion sickness. Academic, London, pp 174–181
Reason JT, Graybiel A (1969) Adaptation to coriolis accelerations: its transfer to the opposite direction of rotation as a function of interventing activity at zero velocity. NAMI-1086, NASA Order R-93, Naval Aerospace Medical Institute, Pensacola
Shaw JE, Chandrasekaran KR (1978) Controlled topical delivery of drugs for systemic action. Drug Metab Rev 8: 223–233
Sinha R (1968) Effect of vestibular coriolis reaction on respiration and blood flow changes in man. Aerospace Med 39: 837–844
Stott JRR, Bagshaw M (1984) The current status of the RAF programme of desensitisation for motion sick aircrew. In: Motion sickness: mechanisms, prediction, prevention and treatment. AGARD-CP-372:40, 1–9. AGARD/NATO, Neuilly-sur-Seine
Stott JRR, Hubble MP, Spencer MB (1984) A double blind comparative trial of powdered ginger root, hyoscine hydrobroide and cinnarizine in the prophylaxis of motion sickness induced by cross coupled stimulation. In: Motion sickness: mechanisms, prediction, prevention and treatment. AGARD-CP-372:39, 1–6. AGARD/NATO, Neuilly-sur-Seine
Triesman M (1977) Motion sickness: an evolutionary hypothesis. Science 197: 493–495
Tucker GJ, Hand DJ, Godbey AL, Reinhardt RF (1965) Airsickness in student aviators. NSAM-939. Naval School of Aviation Medicine, Pensacola
Turnbull R, Chinn HL (1960) The effect of certain drugs on the incidence of seasickness. Clin Pharmacol Ther 1: 280–283
Vogel H, Kohlhaas R, von Baumgarten RJ (1982) Dependence of motion sickness in automobiles on the direction of linear acceleration. Eur J Appl Physiol 48: 399–405
Waespe W, Henn V (1977) Neuronal activity in the vestibular nuclei of the alert monkey during vestibular and optokinetic stimulation. Exp Brain Res 27: 523–538
Waespe W, Henn V (1978) Conflicting visual-vestibular stimulation and vestibular nucleus activity in alert monkeys. Exp Brain Res 33: 203–211
Wang SC, Borison HL (1952) A new concept of the organisation of the central emetic mechanism: recent studies on the sites of action of apomorphine, copper sulphate and cardiac glycosides. Gastroenterology 22: 1–12
Wang SC, Chinn HI (1954) Experimental motion sickness in dogs. Functional importance of chemoceptive emetic trigger zone. Am J Physiol 178: 111–116
Wang SC, Chinn HI (1956) Experimental motion sickness in dogs. Importance of labyrinth and vestibular cerebellum. Am J Physiol 185: 617–623
Wang SC, Chinn HI, Renzi AA (1957) Experimental motion sickness in dogs: role of abdominal visceral afferents. Report No 57–112, School of Aviation Medicine, Randolph AFB, Texas
Wilding JM, Meddis R (1972) Personality correlates of motion sickness. Br J Psychol 63: 619–620
Wood CD (1965) Anti-motion sickness drugs for aerospace. In: 1st Symposium on the role of the vestibular organs in the exploration of space. NASA SP-77:365–371. Scientific and Technical Information Division, NASA, Washington, DC
Wood CD (1970) Anti-motion sickness therapy. In: 5th Symposium on the role of the vestibular organs in space exploration. NASA SP-314:109–114. Scientific and Technical Information Office, NASA, Washington, DC
Wood CD, Graybiel A (1968) Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions. NAMI-982, Naval Aerospace Medical Institute, Pensacola
Young LR, Oman CM, Watt DGD, Money KE, Lichtenberg BK (1984) Spatial orientation in weightlessness and re-adaptation to earth’s gravity. Science 225: 205–208
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Stott, J.R.R. (1986). Mechanisms and Treatment of Motion Illness. In: Davis, C.J., Lake-Bakaar, G.V., Grahame-Smith, D.G. (eds) Nausea and Vomiting: Mechanisms and Treatment. Advances in Applied Neurological Sciences, vol 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70479-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-70479-6_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70481-9
Online ISBN: 978-3-642-70479-6
eBook Packages: Springer Book Archive